We noted that TUBA1B overexpression is linked to key immune-related pathways in the tumor immune microenvironment (TIME), such as IL-6/JAK/STAT3 signaling, IL-2/STAT5 signaling, TGF-Beta signaling, and interferon responses (Xu et al., 2024). The gene discussed is IL2; the disease is neoplasm.